Uboldo, Italy

Ameriga Lazzarini


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Ameriga Lazzarini

Introduction

Ameriga Lazzarini is a notable inventor based in Uboldo, Italy. He has made significant contributions to the field of chemistry, particularly in the development of methods for protecting carboxy groups in compounds of the β-lactam type. His innovative approach has implications for various applications in pharmaceutical chemistry.

Latest Patents

Lazzarini holds a patent for a method of protection of the carboxy groups in the chemistry of β-lactam compounds. The patent describes a new method where the carboxy group is transformed into its corresponding phenyl-acetoxy-methyl ester. This ester can then be removed through an enzymatic route using penicillinacylase. Notably, if the β-lactam compound also contains a phenyl-acetamidic substituent, this substituent is hydrolyzed simultaneously during the removal of the carboxy function protecting group. This innovative method enhances the efficiency of chemical processes involving β-lactam compounds.

Career Highlights

Ameriga Lazzarini is associated with Sclavo Spa, a company known for its contributions to biopharmaceuticals. His work at Sclavo Spa has allowed him to focus on innovative solutions in the field of chemistry. Lazzarini's patent reflects his commitment to advancing chemical methodologies and improving pharmaceutical applications.

Collaborations

Lazzarini has collaborated with notable colleagues, including Claudio Fuganti and Eva Baldaro. These collaborations have fostered a productive environment for innovation and research within the company.

Conclusion

Ameriga Lazzarini's contributions to the field of chemistry, particularly through his patented method for protecting carboxy groups, highlight his role as an influential inventor. His work continues to impact the pharmaceutical industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…